Becton Dickinson to invest $30M in IV production capacity
Becton Dickinson plans to invest more than $30M in 2025 to expand its manufacturing capacity for IV lines at its Utah plant.
PharmiWeb21h
Vetter Introduces the Next Evolution of the V-OVS® Syringe Closure System
Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has announced the development and upcoming launch of the new version of its proprietary V-OVS® syringe closure ...